Cargando…
Identification of epidermal growth factor receptor-derived peptides immunogenic for HLA-A2(+) cancer patients
Epidermal growth factor receptor (EGFR) is one of the most appropriate target molecules for cancer therapy because of its relatively high expression in about one-third of all epithelial cancers in correlation with neoplasmic progression. With respect to EGFR-targeted therapies, antibodies and tyrosi...
Autores principales: | Shomura, H, Shichijo, S, Matsueda, S, Kawakami, T, Sato, Y, Todo, S, Itoh, K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409701/ https://www.ncbi.nlm.nih.gov/pubmed/15083186 http://dx.doi.org/10.1038/sj.bjc.6601728 |
Ejemplares similares
-
Identification of parathyroid hormone-related protein-derived peptides immunogenic in human histocompatibility leukocyte antigen-A24(+) prostate cancer patients
por: Yao, A, et al.
Publicado: (2004) -
Heat shock cognate protein 70 encodes antigenic epitopes recognised by HLA-B4601-restricted cytotoxic T lymphocytes from cancer patients
por: Azuma, K, et al.
Publicado: (2003) -
UDP-Gal: βGlcNAc β1, 3-galactosyltransferase, polypeptide 3 (GALT3) is a tumour antigen recognised by HLA-A2-restricted cytotoxic T lymphocytes from patients with brain tumour
por: Tsuda, N, et al.
Publicado: (2002) -
Identification of an HLA-A(*)0201-restricted T-cell epitope derived from the prostate cancer-associated protein prostein
por: Kiessling, A, et al.
Publicado: (2004) -
Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence
por: Hernes, E, et al.
Publicado: (2004)